Experimental and applied effect of Shudha Tankana in perspective of Hetuvyadhiviprita chikista siddhant w.s.r. to Dadru

Experimental and applied effects of Shudha Tankana in perspective of Hetuvtadhiviprita chikista sidhant with respect to Dadru

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/02/012243

Enrollment

Registered

2018-02-28

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients with symptoms and leasion of fungal infection

Interventions

Intervention1: Shudha tankana ointment: Shuda tankana ointment will be applied topically on lesion Intervention2: Shudha tankana capsules: shudha tankana capsules will be given orally 250 mg b.i.d. In

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients suffering from fungal infections 2 Clinical chemistry and hematology results from visit 1 are within normal limits. 3 Non pregnant female and must agree to use adequate method of contraception during the study.

Exclusion criteria

Exclusion criteria: 1 Age less than 18 years and not more than 60 years Evidence of alcohol or drug abuse. 2 Patients suffering from any critical disease of vital organs and chronic diseases like cancer, AIDS,TB etc.

Design outcomes

Primary

Measure	Time frame
Decrease in severity of symptoms from severe to absentTimepoint: 45 days	—

Secondary

Measure	Time frame
UnimprovedTimepoint: 45 days	—

Countries

India

Contacts

Public ContactAnshu Pathania

Rajeev Gandhi post graduate ayurvedic college paprola

pathanianshu5@gmail.com8894950179

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026